Eton Pharmaceuticals, Inc. (ETON)
57.69
-1.80
(-3.03%)
USD |
NASDAQ |
Sep 25, 16:00
57.69
0.00 (0.00%)
After-Hours: 19:08
Eton Pharmaceuticals Cash from Operations (TTM) : 15.14M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.14M |
| March 31, 2026 | 15.84M |
| December 31, 2025 | 10.52M |
| September 30, 2025 | 21.31M |
| June 30, 2025 | 12.24M |
| March 31, 2025 | 5.532M |
| December 31, 2024 | 0.969M |
| September 30, 2024 | 2.121M |
| June 30, 2024 | 0.042M |
| March 31, 2024 | 5.89M |
| December 31, 2023 | 6.815M |
| September 30, 2023 | 9.268M |
| June 30, 2023 | 6.692M |
| March 31, 2023 | 2.05M |
| December 31, 2022 | 4.821M |
| September 30, 2022 | -3.136M |
| June 30, 2022 | -4.383M |
| Date | Value |
|---|---|
| March 31, 2022 | -7.213M |
| December 31, 2021 | -4.721M |
| September 30, 2021 | -6.786M |
| June 30, 2021 | -8.93M |
| March 31, 2021 | -11.41M |
| December 31, 2020 | -22.35M |
| September 30, 2020 | -19.01M |
| June 30, 2020 | -17.13M |
| March 31, 2020 | -18.48M |
| December 31, 2019 | -18.03M |
| September 30, 2019 | -15.95M |
| June 30, 2019 | -15.03M |
| March 31, 2019 | -13.06M |
| December 31, 2018 | -8.145M |
| September 30, 2018 | -7.439M |
| June 30, 2018 | -7.353M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Nektar Therapeutics | -233.79M |
| Pfizer Inc. | 13.40B |
| Elite Pharmaceuticals, Inc. | 19.04M |
| Daré Bioscience, Inc. | -11.29M |
| Liquidia Corp. | 167.71M |